-+ 0.00%
-+ 0.00%
-+ 0.00%

Ascendiant Capital Maintains Buy on Aemetis, Raises Price Target to $22

Benzinga·05/22/2026 12:05:56
Listen to the news
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and raises the price target from $21 to $22.